Dechra Pharmaceuticals

Dechra Pharmaceuticals reported Total CO2e Emissions - Location-Based Scope 1 + Scope 2 for the twelve months ending 30 June 2021 at 12 Kt (+0.57/+4.9% y-o-y). At the sime time, carbon intensity declined to 16 t (-1.8 /-10.1% y-o-y).

Dechra Pharmaceuticals's Scope 3 emissions was down at 1.9 Kt (-0.41 /-17.6% y-o-y). The decline accelerated compared to the CAGR of -7.2% since 2Q'19.

The company has not set a company-wide target for an absolute reduction in GHG emissions yet.

Dechra Pharmaceuticals also has a science-based goal that, however, does not appear to explicitly target a company-wide reduction in emissions in absolute terms. New World Development Company Limited commits to reduce absolute scope 1 and 2 GHG emissions 46.2% by FY2030 from a FY2019 base year. New World Development Company Limited also commits to reduce scope 3 GHG emissions from capital goods 22% per square meter of construction floor area by FY2030 from a FY2019 base year. New World Development Company Limited further commits to reduce scope 3 GHG emissions from downstream leased assets 29.8% per square meter of gross floor space within the same timeframe